Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)
BulgariaLong-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy
SpainLong-Term Safety Study of Gene Therapy with Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome
FranceStudy of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis
BelgiumStudy on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma
PortugalPET/CT Imaging Study for Patients with Giant Cell Arteritis or Rheumatoid Arthritis Using Zirconium (89Zr) Crefmirlimab Berdoxam
The NetherlandsStudy of Sarilumab for Patients with Rheumatoid Arthritis Not Responding to Anti-TNF Therapy
BelgiumStudy on Stopping Prednisolone Early in Patients with Negative FDG-PET/CT and Idiopathic Retroperitoneal Fibrosis
FranceStudy on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn's Disease
BelgiumStudy of Mirikizumab for Children with Moderate to Severe Crohn's Disease
AustriaStudy on the Effect of Clobetasol Propionate on Bone Mineral Density in Patients with Bullous Pemphigoid
FranceLong-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
CyprusThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
